The Great RIF(T): One FDA Division’s Destruction and What it Could Mean for Generic Drugs
The FDA Law Blog
APRIL 8, 2025
OGDP is one of several offices in OGD, and it was composed of three divisions: the Division of Legal and Regulatory Support, the Division of Orange Book Publication and Regulatory Assessment, and the Division of Policy Development (DPD). Providing significant policy support to the annual update of the Orange Book Preface.
Let's personalize your content